Gross-to-Net August 29, 2023 Improving Gross-to-Net Estimates through Better Channel Analytics Part 2 2 Minute Read This is the second installment of our two-part blog post covering our webinar series discussing the advantages that channel analytics and downstream inventory analytics have when it comes to...
Gross-to-Net August 3, 2023 Improving Gross-to-Net Estimates through Better Channel Analytics 4 Minute Read This is the first installment of our two-part blog post covering our webinar series discussing the advantages that channel analytics and downstream inventory analytics have when it comes to...
Gross-to-Net June 8, 2023 Monitoring the Gross-to-Net Impacts of WAC Price Increases 2 Minute Read Manufacturers considering taking a WAC price increase this year should be aware of the impact on their GTN line items.
Gross-to-Net April 17, 2023 Why Modernize Your Gross-to-Net? 5 Benefits of Pharma Digital Transformation 2 Minute Read In the current pharma landscape, more than 80% of manufacturers still rely on manual processes to accrue, forecast, and report their gross-to-net (GTN) deductions. This is primarily because of...
Gross-to-Net March 6, 2023 5 Pharma Gross-to-Net Questions You Should Be Asking 4 Minute Read Whether manufacturers are entering new therapeutic categories, exploring new indications for a current product, or looking to acquire a new product through acquisition, managing Gross-To-Net can be complex.
Gross-to-Net February 3, 2022 Forecasting for the Future 2 Minute Read How manufacturers can leverage successful returns and inventory pipeline reserve methodologies for long-term benefits.
Gross-to-Net January 28, 2021 Five Steps to GTN Implementation Success 3 Minute Read Pharmaceutical manufacturers can achieve GTN implementation success on day one of a new product launch by following these five best practices.
Gross-to-Net December 10, 2020 Gross-to-Net Roadmap to Launch 3 Minute Read A comprehensive countdown of the Top 10 key gross-to-net (GTN) milestones for manufacturers about to launch their first commercial product.
